Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer

  • Authors:
    • Harun Badakhshi
    • David Kaul
    • Kuai‑Le Zhao
  • View Affiliations

  • Published online on: January 28, 2016     https://doi.org/10.3892/mco.2016.753
  • Pages: 643-647
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Locally advanced esophageal cancer has been treated by a multimodality regimen encompassing combined radiochemotherapy (RCT). The tumor response to neoadjuvant RCT is a major determinant of further therapeutic strategies, whether surgery or a continuation of RCT, and therefore, also of the patient's overall prognosis. The present study included patients with histologically proven squamous cell esophageal carcinoma. The C‑reactive protein (CRP) level was measured prior to and following the completion of neoadjuvant RCT. Only CRP measurements taken within 2 weeks of the start of RCT were analyzed. Further measurements were then taken at 6, 12, 18, 24, 30, 36 and 40 weeks following RCT. CRP levels were high prior to treatment; however, eventually decreased and normalized following the therapy. In univariate analysis, pre‑therapeutic CRP levels had a significant influence on the response rate (P=0.033), whilst post‑therapeutic CRP levels had no significant influence (P=0.383). Pre‑therapeutic CRP levels, however, not post‑therapeutic CRP levels were significantly correlated with the response rate (P=0.045 and P=0.444, respectively), and no association was observed between CRP levels and survival. This preliminary data indicated that the pre‑therapeutic serum CRP level is a possible indicator of treatment response to RCT.
View Figures
View References

Related Articles

Journal Cover

April 2016
Volume 4 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Badakhshi, H., Kaul, D., & Zhao, K. (2016). Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer. Molecular and Clinical Oncology, 4, 643-647. https://doi.org/10.3892/mco.2016.753
MLA
Badakhshi, H., Kaul, D., Zhao, K."Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer". Molecular and Clinical Oncology 4.4 (2016): 643-647.
Chicago
Badakhshi, H., Kaul, D., Zhao, K."Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer". Molecular and Clinical Oncology 4, no. 4 (2016): 643-647. https://doi.org/10.3892/mco.2016.753